Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375667 | PMC |
| http://dx.doi.org/10.47626/1516-4446-2021-2359 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ibogaine microdosing in a patient with bipolar depression: a case report.
Braz J Psychiatry
July 2022
Instituto de Psiquiatria (LIM-23), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil.
Ibogaine therapy for addiction: Consumer views from online fora.
Int J Drug Policy
September 2020
Turner Institute for Brain and Mental Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
Background Ibogaine is a psychedelic drug used by for-profit clinics and lay-people to treat addiction, despite some reported fatalities and a lack of rigorous clinical research. Little is known about ibogaine therapy from a consumer perspective. Online discussions generate and disseminate information about ibogaine therapy and provide a window into how people understand ibogaine's risks and uses.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!